by Vora Corporate Finance | Mar 4, 2025 | Insights
Maha Kumbh Mela 2025: A Major Economic Driver for Uttar Pradesh Being held in Prayagraj, Uttar Pradesh, is poised to become one of the largest economic events in the region, with an anticipated turnout of 40-45 crore devotees and tourists. Spanning 10,000 acres, this...
by Vora Corporate Finance | Feb 4, 2025 | Insights
The BSE Sensex closed at 78,139 down by 2.08% and the Nifty 50 closed at 23,645 down by 2.01% in December 2024, amid weakness in IT and select banks. From a sector perspective, leading gainers were Information Technology (+6%), Teck (+5%) Consumer Durables (+3%), and...
by Vora Corporate Finance | Jan 4, 2025 | Insights
There were 15 main board IPOs in December 2024 of Suraksha Diagnostics Limited, as One Mobikwik Systems Limited, Sai Life Sciences Limited, Vishal Mega Mart Limited, Inventurus Knowledge Solutions LIMITED, International Gemmolgical Institue India Limited, Transrail...
by Vora Corporate Finance | Dec 20, 2024 | Insights, Merger & Acquisitions
Transaction: Metropolis Healthcare Limited, India’s second-largest pathology chain acquires 100% stake in oncology-focused diagnostic services provider Core Diagnostics for Rs 246.8 Crore. The acquisition will take place through a combination of cash and stock, with...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
